Oncology Virtual Forum

About

Speakers

Digital Content Hub

Agenda

About

Speakers

Digital Content Hub

Agenda

JOIN NOW

monday, July 26th, 2021 | 1 - 3 pm ct

oncology virtual forum

The COVID-19 pandemic disrupted cancer screenings, care delivery and research. But the disease did not slow down. Experts anticipate patients will seek treatment for more advanced-stage cancers than in the past, and oncology centers across the U.S. are making preparations. Clinicians and researchers are also redesigning the cancer patient journey, developing more sophisticated therapies and relying on cutting-edge technology to take cancer treatment to the next level. During this event, oncology leaders from top institutions will gather for high-level discussions about the industry and what will happen next.

Stay informed with our virtual learning opportunities. Check out our Webinars, Whitepapers, and our E-Newsletters today!

Stay Connected

Bhavesh Shah, Senior Director of Hematology and Oncology and Specialty Pharmacy at Boston Medical Center

Katie Struck, System Vice President and Chief Administrative Officer of Oncology at Rush University System for Health

Ken Komorny, Chief Pharmacy Officer at Moffitt Cancer Center

Karen Ignagni, CEO of EmblemHealth

Dr. Donna Havens, Dean and Professor at the College of Nursing at Villanova University and Dr. Peter Kaufmann, Associate Dean of Research and Innovation at the College of Nursing at Villanova University

Podcasts

AGENDA

speakers

digital hub

oncology virtual forum

VIEW ON DEMAND

RSVP NOW

Add to Calendar GMail | Outlook | iCal

SPECIAL THANKS TO OUR CORPORATE SPONSORS:

Craig A Bunnell, MD, MPH, MBA, Chief Medical Officer, Dana-Farber Cancer Institute Rafael Fonseca, MD, Interim Executive Director, Mayo Clinic Comprehensive Cancer Center; Director for Innovation and Transformational Relationships, Getz Family Professor of Cancer, Distinguished Mayo Investigator Steven N. Kalkanis, MD, Chief Executive Officer, Henry Ford Medical Group; Chief Academic Officer, Henry Ford Health System; Henry Ford II Chair and Senior Vice President, Henry Ford Health System Donna Royster, Administrative Director, Radiation/Oncology, Levine Cancer Institute, Atrium Health

Oncology over the next 5 years: Innovative therapies, telehealth & more

time tba | Panel discussion

View On Demand

Join Session Now

Discussion Topics: • Oncology over the next 5 years: Innovative therapies, telehealth & more • COVID-19 disrupted cancer screenings. Where do we go from here? • How to deliver the cancer care patients really want and thrive in a competitive market Full agenda coming soon!

Craig A Bunnell, MD, MPH, MBA, Chief Medical Officer, Dana-Farber Cancer Institute

Rafael Fonseca, MD, Interim Executive Director, Mayo Clinic Comprehensive Cancer Center; Director for Innovation and Transformational Relationships, Getz Family Professor of Cancer, Distinguished Mayo Investigator

Steven N. Kalkanis, MD, Chief Executive Officer, Henry Ford Medical Group; Chief Academic Officer, Henry Ford Health System; Henry Ford II Chair and Senior Vice President, Henry Ford Health System

Brian J. Bolwell, MD, FACP, Chairman, Taussig Cancer Institute, Professor of Medicine, Cleveland Clinic Lerner School of Medicine

thank you to our sponsors:

Speaker information coming soon!

COVID-19 disrupted cancer screenings. Where do we go from here?

Ifeyinwa (Ify) Osunkwo, MD, MPH, Director, Sickle Cell Disease Enterprise and Professor of Medicine, Levine Cancer Institute; Professor of Medicine and Pediatrics, Atrium Health Ronald Chen, MD, MPH, FASCO, FASTRO, Professor, Joe and Jean Brandmeyer Endowed; Clinical Service Chief, Department of Radiation Oncology; Associate Director of Health Equity, University of Kansas Cancer Center Anthony Ciarolla, MD, MBA, Clinical Assistant Professor, UCLA School of Medicine; Medical Director for Adult Cancer, Long Beach Memorial Medical Center, Long Beach Memorial Medical Center Hospice; President, OPN Healthcare, Inc., Southern California Oncology Associates Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute; Richard and Susan Smith, Professor of Medicine, Harvard Medical School Diana Caragacianu, MD, FACS, Medical Director, Breast Center at Milford Regional Medical Center, Assistant Professor, Breast and Endocrine Surgery, University of Massachusetts Medical School

time tba | Panel discussion

View On Demand

Join Session Now

How to deliver the cancer care patients really want and thrive in a competitive market

Brian J. Bolwell, MD, FACP, Chairman, Taussig Cancer Institute, Professor of Medicine, Cleveland Clinic Lerner School of Medicine Ed Edwards, Director of Materials Management, MD Anderson Cancer Center Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute; Richard and Susan Smith, Professor of Medicine, Harvard Medical School Tatjana Kolevska, MD, Medical Director, Kaiser Permanente National Cancer Excellence Program; Chair of Oncology and Hematology, The Permanente Medical Group

time tba | Panel discussion

View On Demand

Join Session Now

Laurie H. Glimcher, MD, President and Chief Executive Officer, Dana-Farber Cancer Institute; Richard and Susan Smith, Professor of Medicine, Harvard Medical School

Ed Edwards, Director of Materials Management, MD Anderson Cancer Center

Ronald Chen, MD, MPH, FASCO, FASTRO, Professor, Joe and Jean Brandmeyer Endowed; Clinical Service Chief, Department of Radiation Oncology; Associate Director of Health Equity, University of Kansas Cancer Center

Ifeyinwa (Ify) Osunkwo, MD, MPH, Director, Sickle Cell Disease Enterprise and Professor of Medicine, Levine Cancer Institute; Professor of Medicine and Pediatrics, Atrium Health

Diana Caragacianu, MD, FACS, Medical Director, Breast Center at Milford Regional Medical Center, Assistant Professor, Breast and Endocrine Surgery, University of Massachusetts Medical School

Donna Royster, Administrative Director, Radiation/Oncology, Levine Cancer Institute, Atrium Health

Tatjana Kolevska, MD, Medical Director, Kaiser Permanente National Cancer Excellence Program; Chair of Oncology and Hematology, The Permanente Medical Group

RSVP NOW

JOIN NOW

VIEW ON DEMAND

Carol L. Brown, MD, FACOG, FACS, Surgeon, Senior Vice President and Chief Health Equity Officer; Nicholls-Biondi Chair for Health Equity, Memorial Sloan Kettering

Fireside Chat: Cancer Health Equity

Carol L. Brown, MD, FACOG, FACS, Surgeon, Senior Vice President and Chief Health Equity Officer; Nicholls-Biondi Chair for Health Equity, Memorial Sloan Kettering Moderated by Erica Carbajal, Writer/Reporter, Becker's Healthcare

time tba | FIRESIDE CHAT

View On Demand

Join Session Now

Anthony Ciarolla, MD, MBA, Clinical Assistant Professor, UCLA School of Medicine; Medical Director for Adult Cancer, Long Beach Memorial Medical Center, Long Beach Memorial Medical Center Hospice; President, OPN Healthcare, Inc., Southern California Oncology Associates

Using data insights to transform cancer care delivery

The simple solution infusion centers are adopting to solve common scheduling challenges

Webinars

Hot Topics in Cancer Care Delivery and Payment Innovation

Meagan O'Neill, Senior Manager, ECG Management Consultants Matt Sturm, Principal, ECG Management Consultants

time tba | FEATURED SESSION

View On Demand

Join Session Now

Learn More

About

Speakers

Digital Content Hub

Agenda

About

Speakers

Digital Content Hub

Agenda

JOIN NOW

VIEW ON DEMAND

RSVP NOW

Oncology is a complex and unique segment of the US healthcare system, and perhaps no other specialty is as dynamic due to the pace of development and myriad options available to treat various cancers. As the overall cost of treating cancer exceeds $100 billion annually, the US oncology marketplace is under pressure to adapt and innovate to ensure patients receive the care they need while programs remain financially viable. This presentation provides a crash course on the latest trends and “hot topic” issues driving change for cancer centers across the country, including how to enhance payer relationships and fee-for-service reimbursement, pursue transformative payment models and oncology value-based care, optimize key operational performance areas, and better understand market differentiation opportunities through radiation oncology technology or other strategic program initiatives. Join this session to learn what your program must have on the radar going into 2022 and potential strategies to proactively address oncology market changes or best prepare for their future implications.

Meagan O'Neill, Senior Manager, ECG Management Consultants

Matt Sturm, Principal, ECG Management Consultants

Hot Topics in Cancer Care Delivery and Payment Innovation